132 related articles for article (PubMed ID: 9082941)
1. The effects of functional suppression of a membrane-bound complement regulatory protein, CD59, in the synovial tissue in rats.
Mizuno M; Nishikawa K; Goodfellow RM; Piddlesden SJ; Morgan BP; Matsuo S
Arthritis Rheum; 1997 Mar; 40(3):527-33. PubMed ID: 9082941
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59.
Mizuno M; Nishikawa K; Morgan BP; Matsuo S
Clin Exp Immunol; 2000 Feb; 119(2):368-75. PubMed ID: 10632677
[TBL] [Abstract][Full Text] [Related]
3. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
[TBL] [Abstract][Full Text] [Related]
4. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
[TBL] [Abstract][Full Text] [Related]
5. Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats.
Mizuno M; Nishikawa K; Spiller OB; Morgan BP; Okada N; Okada H; Matsuo S
Arthritis Rheum; 2001 Oct; 44(10):2425-34. PubMed ID: 11665985
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats.
Matsuo S; Ichida S; Takizawa H; Okada N; Baranyi L; Iguchi A; Morgan BP; Okada H
J Exp Med; 1994 Nov; 180(5):1619-27. PubMed ID: 7525834
[TBL] [Abstract][Full Text] [Related]
7. Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase.
Nishikawa K; Matsuo S; Okada N; Morgan BP; Okada H
J Immunol; 1996 Feb; 156(3):1182-8. PubMed ID: 8557996
[TBL] [Abstract][Full Text] [Related]
8. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane.
Konttinen YT; Ceponis A; Meri S; Vuorikoski A; Kortekangas P; Sorsa T; Sukura A; Santavirta S
Ann Rheum Dis; 1996 Dec; 55(12):888-94. PubMed ID: 9014582
[TBL] [Abstract][Full Text] [Related]
9. Role of CD59 in experimental glomerulonephritis in rats.
Matsuo S; Nishikage H; Yoshida F; Nomura A; Piddlesden SJ; Morgan BP
Kidney Int; 1994 Jul; 46(1):191-200. PubMed ID: 7523753
[TBL] [Abstract][Full Text] [Related]
10. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury.
Zhang J; Hu W; Xing W; You T; Xu J; Qin X; Peng Z
Am J Pathol; 2011 Dec; 179(6):2876-84. PubMed ID: 22019898
[TBL] [Abstract][Full Text] [Related]
11. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies.
Kemp PA; Spragg JH; Brown JC; Morgan BP; Gunn CA; Taylor PW
J Clin Lab Immunol; 1992; 37(4):147-62. PubMed ID: 1285067
[TBL] [Abstract][Full Text] [Related]
13. Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.
Nomura A; Nishikawa K; Yuzawa Y; Okada H; Okada N; Morgan BP; Piddlesden SJ; Nadai M; Hasegawa T; Matsuo S
J Clin Invest; 1995 Nov; 96(5):2348-56. PubMed ID: 7593622
[TBL] [Abstract][Full Text] [Related]
14. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).
Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS
J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365
[TBL] [Abstract][Full Text] [Related]
15. Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats.
Mizuno M; Ito Y; Mizuno T; Harris CL; Suzuki Y; Okada N; Matsuo S; Morgan BP
Am J Physiol Renal Physiol; 2012 May; 302(10):F1245-51. PubMed ID: 22338087
[TBL] [Abstract][Full Text] [Related]
16. Identification of mutations in rat CD59 that increase the complement regulatory activity.
Hinchliffe SJ; Morgan BP
Biochemistry; 2000 May; 39(19):5831-7. PubMed ID: 10801333
[TBL] [Abstract][Full Text] [Related]
17. Complement membrane attack complex and protectin (CD59) in liver allografts during acute rejection.
Lautenschlager I; Höckerstedt K; Meri S
J Hepatol; 1999 Sep; 31(3):537-41. PubMed ID: 10488715
[TBL] [Abstract][Full Text] [Related]
18. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9.
Farkas I; Baranyi L; Ishikawa Y; Okada N; Bohata C; Budai D; Fukuda A; Imai M; Okada H
J Physiol; 2002 Mar; 539(Pt 2):537-45. PubMed ID: 11882685
[TBL] [Abstract][Full Text] [Related]
19. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
[TBL] [Abstract][Full Text] [Related]
20. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.
Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S
Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
